Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: A longitudinal study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 171, Issue 2, 2013, Pages 225-230

  Rizos, Demetrios ^a   Eleftheriades, Makarios ^b   Karampas, Gregory ^c   Rizou, Myrto ^d   Haliassos, Alexander ^d   Hassiakos, Dimitrios ^a   Vitoratos, Nikolaos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EmbryoCare   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d Diamedica   (Greece)

Author keywords

PlGF; Preeclampsia; Pregnancy; sFlt 1; sFlt 1 to PlGF ratio; SGA; Slope PlGF; Small for gestational age

Indexed keywords

PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; LONGITUDINAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY; UTERINE ARTERY DOPPLER PULSATILITY INDEX;

PLGF; PREECLAMPSIA; PREGNANCY; SFLT-1; SFLT-1 TO PLGF RATIO; SGA; SLOPE PLGF; SMALL FOR GESTATIONAL AGE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84890433364     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.08.040     Document Type: Article

References (30)

1. ACOG practice bulletin Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002 Int J Gynaecol Obstet 77 2002 67 75
2. D. Roussos, D. Panidis, V. Tsimas, A. Kourtis, and M. Mamopoulos Preeclampsia-eclampsia in Greece Hellen Obstet Gynacol 15 2003 37 44
3. B.C. Young, R.J. Levine, and S.A. Karumanchi Pathogenesis of preeclampsia Annu Rev Pathol 5 2010 173 192
4. I. Agarwal, and S.A. Karumanchi Preeclampsia and the anti-angiogenic state Pregnancy Hypertens 1 2011 17 21
5. J. Espinoza, J.E. Uckele, R.A. Starr, R.P. Lorenz, R.A. Bronsteen, and S.M. Berry Insights into angiogenic imbalances during pregnancy Obstet Gynecol 114 2009 437 440
6. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
7. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
8. E. Shibata, A. Rajakumar, and R.W. Powers Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor J Clin Endocrinol Metab 90 2005 4895 4903
9. T. Chaiworapongsa, J. Espinoza, and F. Gotsch The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation J Matern Fetal Neonatal Med 21 2008 25 40
10. T.A. Moore Simas, S.L. Crawford, M.J. Solitro, S.C. Frost, B.A. Meyer, and S.E. Maynard Angiogenic factors for the prediction of preeclampsia in high-risk women Am J Obstet Gynecol 197 2007 244.e1 244.e8
11. S. Verlohren, I. Herraiz, and O. Lapaire The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients Am J Obstet Gynecol 206 2012 58.e1 58.e8
12. Y. Giguère, M. Charland, and E. Bujold Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review Clin Chem 56 2010 361 375
13. S. Bonellie, J. Chalmers, R. Gray, I. Greer, S. Jarvis, and C. Williams Centile charts for birthweight for gestational age for Scottish singleton births BMC Pregn Childbirth 8 2008 5
14. J. Schiettecatte, H. Russcher, and E. Anckaert Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia Clin Biochem 43 2010 768 770
15. S.J. Benton, Y. Hu, and F. Xie Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol 206 163. 2012 e1 e7
16. G. Steinberg, C. Lee, and J.A. Rauh-Hain Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies Am J Obstet Gynecol 202 299 2010 e1 e7
17. R. Thadhani, W.P. Mutter, and M. Wolf First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
18. M. Noori, A.E. Donald, A. Angelakopoulou, A.D. Hingorani, and D.J. Williams Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension Circulation 122 2010 478 487
19. M. Jacobs, N. Nassar, C.L. Roberts, R. Hadfield, J.M. Morris, and A.W. Ashton Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review Reprod Biol Endocrinol 9 2011 77
20. M.U. Baumann, N.A. Bersinger, M.G. Mohaupt, L. Raio, S. Gerber, and D.V. Surbek First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia Am J Obstet Gynecol 199 266 2008 e1 e6
21. G.C.S. Smith, J.A. Crossley, and D.A. Aitken Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 2007 1316 1324
22. R. Akolekar, J. De Cruz, J.M. Foidart, C. Munaut, and K.H. Nicolaides Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia Prenat Diagn 30 2010 191 197
23. N.A. Bersinger, and M.U. Baumann Serum markers for pre-eclampsia: an update on the analytes to be determined in the first, second, and third trimester Immuno-Analyse et Biologie Specialisee 24 2009 58 68
24. R. Akolekar, E. Zaragoza, L.C.Y. Poon, S. Pepes, and K.H. Nicolaides Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia Ultrasound Obstet Gynecol 32 2008 732 739
25. N.J. Cowans, A. Stamatopoulou, E. Matwejew, C.S. Von Kaisenberg, and K. Spencer First-trimester placental growth factor as a marker for hypertensive disorders and SGA Prenat Diagn 30 2010 565 570
26. A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. D'Anna Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia Acta Obstet Gynecol Scand 87 2008 837 842
27. A. Ohkuchi, C. Hirashima, S. Matsubara, K. Takahashi, Y. Matsuda, and M. Suzuki Threshold of soluble Fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia Hypertension 58 2011 859 866
28. J.P. Kusanovic, R. Romero, and T. Chaiworapongsa A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia Prediction of preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
29. F. Crispi, E. Llurba, C. Domínguez, P. Martín- Gallán, L. Cabero, and E. Gratacós Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction Ultrasound Obstet Gynecol 31 2008 303 309
30. A.E. Diab, M.M. El-Behery, M.A. Ebrahiem, and A.E. Shehata Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry Int J Gynecol Obstet 102 2008 146 151